Dr. Paul B. Poommipanit, MD

Dr. Poommipanit practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Poommipanit's NPI, 1487779757, was assigned on March 19, 2007. Dr. Poommipanit graduated from Tulane University School of Medicine in 2003. Dr. Poommipanit holds Georgia license 068541.

Dr. Poommipanit's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Poommipanit's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Poommipanit is also affiliated with Cleveland Clinic Mercy Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Poommipanit to 1 more hospital and 2 clinical labs, each named with a free account. Dr. Poommipanit's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poommipanit practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Poommipanit's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Poommipanit is licensed in Georgia.

CMS data shows 1,304 Medicare services from Dr. Poommipanit across 20 procedure codes in 2024, for 557 Medicare patients. Medicare paid $85,350 for them.

CMS counts 557 Medicare patients who saw Dr. Poommipanit in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poommipanit's median patient age at 67, with 35% women.

In 2024, Dr. Poommipanit wrote 3,290 Medicare Part D claims for 342 patients. 86% of them were for generic drugs. CMS names the drug for 3,146 of them, across 40 drugs with 11 or more claims each, at $451,096 in total drug cost. In 2023, CMS named 2,818 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Poommipanit for performance year 2024, reported through an alternative payment model (APM). Dr. Poommipanit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poommipanit as offering telehealth. CMS counts 69 procedures of coronary angioplasty and stenting by Dr. Poommipanit, more than 91% of the clinicians it reports for that procedure.

CMS Open Payments shows 879 general payments to Dr. Poommipanit from 47 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Abbott Laboratories paid the most, $88,587. It also lists 1 research payment totaling $134 in 2023.

Dr. Poommipanit graduated from Tulane University School of Medicine in 2003.